Back to search

The treatment of neurogenic orthostatic hypotension with 3,4-DL-threo-dihydroxyphenylserine

Data up to Jan 2025

Published1999
Citations97
References24
Clinical Trials (1)

Total Citations Per Year

Abstract

References (24)

A Neurological Syndrome Associated with Orthostatic Hypotension

1960 • 737 citations

Efficacy of midodrine vs placebo in neurogenic orthostatic hypotension. A randomized, double-blind multicenter study. Midodrine Study Group

1997 • 389 citations

Efficacy of Midodrine vs Placebo in Neurogenic Orthostatic Hypotension

1997 • 375 citations

Postural hypotension

1925 • 361 citations

The Sympathetic-Nervous-System Defect in Primary Orthostatic Hypotension

1977 • 353 citations

Patterns of plasma levels of catechols in neurogenic orthostatic hypotension

1989 • 157 citations

Treatment of orthostatic hypotension due to autonomic failure with a peripheral alpha‐adrenergic agonist (midodrine)

1988 • 132 citations

Depletion of catecholaminergic neurons of the rostral ventrolateral medulla in multiple systems atrophy with autonomic failure

1998 • 131 citations

ENDOGENOUS RESTORATION OF NORADRENALINE BY PRECURSOR THERAPY IN DOPAMINE-BETA-HYDROXYLASE DEFICIENCY

1987 • 110 citations

Medullary catecholaminergic neurons in the normal human brain and in Parkinson's disease

1991 • 84 citations

The definition of orthostatic hypotension, pure autonomic failure, and multiple system atrophy

1996 • 79 citations

The stereoisomers of 3,4-dihydroxyphenylserine as precursors of norepinephrine.

1975 • 75 citations

Effect of protein ingestion on urinary dopamine excretion. Evidence for the functional importance of renal decarboxylation of circulating 3,4-dihydroxyphenylalanine in man.

1986 • 69 citations

Effect of L‐threo‐3,4‐dihydroxy‐phenylserine on muscle sympathetic nerve activities in Shy‐Drager syndrome

1988 • 60 citations

EFFECT OF UNNATURAL NORADRENALINE PRECURSOR ON SYMPATHETIC CONTROL AND ORTHOSTATIC HYPOTENSION IN DOPAMINE-BETA-HYDROXYLASE DEFICIENCY

1987 • 58 citations

Characteristics of enzymic decarboxylation of L-threo-3,4-dihydroxyphenylserine using hog renal L-aromatic amino acid decarboxylase

1978 • 48 citations

The treatment of postprandial hypotension in autonomic failure with 3,4-DL-threo-dihydroxyphenylserine

1996 • 42 citations

Pharmacokinetic studies of oral L-threo-3,4-dihydroxyphenylserine in normal subjects and patients with familial amyloid polyneuropathy

1982 • 41 citations

Decrease of medullary catecholaminergic neurons in multiple system atrophy and Parkinson's disease and their preservation in amyotrophic lateral sclerosis

1995 • 33 citations

Differential effect of L-threo-3,4-dihydroxyphenylserine in pure autonomic failure and multiple system atrophy with autonomic failure

1991 • 30 citations

The Treatment of Autonomic Dysfunction

1993 • 29 citations

Reversal of the reserpine-induced ptosis by l-threo-3,4-dihydroxy-phenylserine (l-threo-DOPS), a (?)-norepinephrine precursor, and its potentiation by imipramine or nialamide

1986 • 19 citations

The Treatment of Orthostatic Hypotension With Dihydroxyphenylserine

1991 • 16 citations

Positive chronotropic effect of threo-3,4-dihydroxyphenylserine as a precursor of noradrenaline in rat isolated atria

1978 • 10 citations

Cited By (0)

Loading...